...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith shares

I do not have first hand knowledge. I know that it has been done on a number of occasions. Contact a potential seller, in this case dadeo and deal between your brokerages or contact the company to see if they know of anyone that wants to sell. Once a buyer and seller is introduced it is up to them to work out any details. Expect to pay fees as it is not an electronic transaction and there would be a number parties involved. The cost to the buyer and/or seller may be in excess of $500 each.

tada

Share
New Message
Please login to post a reply